[
    [
        {
            "time": "",
            "original_text": "流感“高烧不退” 两类抗流感药物销售可观(受益股)",
            "features": {
                "keywords": [
                    "流感",
                    "高烧不退",
                    "抗流感药物",
                    "销售可观",
                    "受益股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "流感“高烧不退” 两类抗流感药物销售可观(受益股)",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]